Age-Specific Presentation and Management of Congestive Cardiac Failure

Pediatric CCF (Infancy and Childhood)

Pulmonary valvular stenosis (PVS) is present in approximately 45% of children with cardiac issues, while hypertrophic cardiomyopathy (HCM) occurs in nearly 40% of affected children 1
Management of pediatric HCM may include β-blocker medications or surgical procedures such as myomectomy to decrease outflow obstruction in severe cases 1, 2
Early consultation with a pediatric cardiologist and echocardiography is essential once CCF is recognized 1

Adults with CCF typically present with classic symptoms including dyspnea, fatigue, and fluid retention 3
Different types of cardiomyopathies are a common cause of CCF in adults 4
Early invasive strategy and revascularization as appropriate for those with underlying coronary disease 6

Coronary artery disease is the leading cause of CCF in elderly patients 5
Prevalent coronary heart disease is a significant risk factor for developing CCF in the elderly 5
Stroke or TIA is a risk factor for developing CCF in the elderly 5
Diabetes is a risk factor for developing CCF in the elderly 3
Systolic hypertension is a risk factor for developing CCF in the elderly 5
Mortality increases incrementally with advancing age across all stages of cardiogenic shock 5, 4

Pharmacotherapy must be individualized and dose-adjusted by weight and/or creatinine clearance to reduce adverse events due to age-related changes in pharmacokinetics/dynamics in older adults 6
Medication dosing should account for volume of distribution changes, comorbidities, drug interactions, and increased drug sensitivity in older adults 6
Management decisions should be patient-centered, considering patient preferences/goals, comorbidities, functional and cognitive status, and life expectancy in older adults 6
Bivalirudin is preferable to GP IIb/IIIa inhibitors plus UFH in elderly patients with underlying coronary disease due to less bleeding risk 6
CABG may be preferable to PCI in appropriate elderly candidates, particularly those with diabetes or complex 3-vessel CAD 6

Renal function assessment is crucial, especially in older patients, with medication doses adjusted accordingly 6
Bleeding risk increases with age, requiring careful anticoagulation management 6
Interdisciplinary team approach is essential for optimal management of CCF in all age groups, but particularly in the elderly 5, 4

Underdiagnosis in elderly patients due to attributing symptoms to aging or comorbidities 3
Excessive medication dosing in older patients leading to increased adverse effects, particularly bleeding 6
Inadequate attention to quality of life considerations, particularly in elderly patients 5